Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

The K5 promoter controls gene expression in skin cells, with specific DNA segments crucial for targeting and regulation.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Glypicans help hair follicle stem cells differentiate by interacting with specific receptors, influencing hair growth.

The document covers various dermatological treatments and conditions.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The document does not provide information about hair loss treatment.

miR-370-3p slows sheep hair cell growth by blocking SMAD4.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

A method was found to select hair follicle stem cells, and beta-catenin helps them grow and change.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.